Quantum dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung

References

• Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. 2004. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 15:79–86.
   PubMed Web of Science ®Google Scholar
• Chan WH, Shiao NH, Lu PZ. 2006. CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals. Toxicol Lett 167:191–200.
   PubMed Web of Science ®Google Scholar
• Chang E, Thekkek N, Yu WW, Colvin VL, Drezek R. 2006. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2:1412–1417.
   PubMed Web of Science ®Google Scholar
• Chen AA, Derfus AM, Khetani SR, Bhatia SN. 2005. Quantum dots to monitor RNAi delivery and improve gene silencing. Nucleic Acids Res 33:e190.
   PubMed Web of Science ®Google Scholar
• Chen ES, Moller DR. 2007. Expression profiling in granulomatous lung disease. Proc Am Thorac Soc 4:101–107.
   PubMedGoogle Scholar
• Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, Heine JR, Mattoussi H, Ober R, 1997. (CdSe)ZnS core-shell quantum dots: Synthesis and characterization of a size series of highly luminescent nanocrystallites. J Phys Chem 101:9463–9475.
   Web of Science ®Google Scholar
• Denis M, Bedard M, Laviolette M, Cormier Y. 1993. A study of monokine release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lung. Am Rev Respir Dis 147:934–939.
   PubMed Web of Science ®Google Scholar
• Deng Z, Schulz O, Lin S, Ding B, Liu X, Wei X, 2010. Aqueous synthesis of zinc blende CdTe/CdS magic-core/thick-shell tetrahedral-shaped nanocrystals with emission tunable to near-infrared. J Am Chem Soc 132:5592–5593.
   PubMed Web of Science ®Google Scholar
• Erdely A, Hulderman T, Salmen R, Liston A, Zeidler-Erdely PC, Schwegler-Berry D, 2009. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett 9:36–43.
   PubMed Web of Science ®Google Scholar
• Ferrara A2011. Chronic obstructive pulmonary disease. Radiol Technol 82:245–263.
   PubMedGoogle Scholar
• Fujimori Y, Kataoka M, Tada S, Takehara H, Matsuo K, Miyake T, 2003. The role of interleukin-8 in interstitial pneumonia. Respirology 8:33–40.
   PubMed Web of Science ®Google Scholar
• Gao X, Cui Y, Levenson RM, Chung LW, Nie S. 2004. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969–976.
   PubMed Web of Science ®Google Scholar
• Gao X, Dave SR. 2007. Quantum dots for cancer molecular imaging. Adv Exp Med Biol 620:57–73.
   PubMed Web of Science ®Google Scholar
• Gao X, Wang T, Wu B, Chen J, Yue Y, Dai N, 2008. Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles. Biochem Biophys Res Commun 377:35–40.
   PubMed Web of Science ®Google Scholar
• Gaspar MM, Gobbo O, Ehrhardt C. 2010. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers. J Liposome Res 20:55–61.
   PubMed Web of Science ®Google Scholar
• Girard M, Israel-Assayag E, Cormier Y. 2004. Pathogenesis of hypersensitivity pneumonitis. Curr Opin Allergy Clin Immunol 4:93–98.
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Bosch A, Davidson BL, Berg DJ, Hunninghake GW. 1998. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol 19:812–818.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Sato S, Takehara K. 1999. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 117:159–165.
   PubMed Web of Science ®Google Scholar
• Hauck TS, Anderson RE, Fischer HC, Newbigging S, Chan WC. 2010. In vivo quantum-dot toxicity assessment. Small 6:138–144.
   PubMed Web of Science ®Google Scholar
• Henry CJ, Ornelles DA, Mitchell LM, Brzoza-Lewis KL, Hiltbold EM. 2008. IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 181:8576–8584.
   PubMed Web of Science ®Google Scholar
• Jia N, Lian Q, Shen H, Wang C, Li X, Yang Z. 2007. Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by functionalized multiwalled carbon nanotubes. Nano Lett 7:2976–2980.
   PubMed Web of Science ®Google Scholar
• Karathanasis E, Ayyagari AL, Bhavane R, Bellamkonda RV, Annapragada AV. 2005. Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Control Release 103:159–175.
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Ladel CH. 1994. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology 191:509–519.
   PubMed Web of Science ®Google Scholar
• Lam CW, James JT, McCluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126–134.
   PubMed Web of Science ®Google Scholar
• Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 187:655–660.
   PubMed Web of Science ®Google Scholar
• Lin CH, Yang MH, Chang LW, Yang CS, Chang H, Chang WH, 2011. Cd/Se/Te-based quantum dot 705 modulated redox homeostasis with hepatotoxicity in mice. Nanotoxicology. Posted online on December 10, 2010. (doi:10.3109/17435390.2010.539712)
   Web of Science ®Google Scholar
• Lin P, Chen JW, Chang LW, Wu JP, Redding L, Chang H, 2008. Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice. Environ Sci Technol 42:6264–6270.
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q, 2008. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 356:333–344.
   PubMed Web of Science ®Google Scholar
• Lovric J, Cho SJ, Winnik FM, Maysinger D. 2005. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 12:1227–1234.
   PubMed Web of Science ®Google Scholar
• Mahto SK, Park C, Yoon TH, Rhee SW. 2010. Assessment of cytocompatibility of surface-modified CdSe/ZnSe quantum dots for BALB/3T3 fibroblast cells. Toxicol In Vitro 24:1070–1077.
   PubMed Web of Science ®Google Scholar
• Manabe N, Hoshino A, Liang YQ, Goto T, Kato N, Yamamoto K2006. Quantum dot as a drug tracer in vivo. IEEE Trans Nanobioscience 5:263–267.
   PubMed Web of Science ®Google Scholar
• Mansour HM, Rhee YS, Wu X. 2009. Nanomedicine in pulmonary delivery. Int J Nanomedicine 4:299–319.
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Meng X, Sheridan BC, McIntyre RC Jr, Harken AH, Banerjee A. 1998. Tissue-specific protein kinase C isoforms differentially mediate macrophage TNFalpha and IL-1beta production. Shock 9:256–260.
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234:222–235.
   PubMed Web of Science ®Google Scholar
• Mulder WJ, Strijkers GJ, Nicolay K, Griffioen AW. 2010. Quantum dots for multimodal molecular imaging of angiogenesis. Angiogenesis 13:131–134.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, 2004. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 78:1665–1674.
   PubMed Web of Science ®Google Scholar
• Nathan N, Denizot Y. 1998. Anti-inflammatory cytokines (IL-4, IL-10, IL-13) in plasma during mesenteric infarction. Mediators Inflamm 7:119.
   PubMed Web of Science ®Google Scholar
• Nenan S, Boichot E, Lagente V, Bertrand CP. 2005. Macrophage elastase (MMP-12): a pro-inflammatory mediator? Mem Inst Oswaldo Cruz 100(Suppl 1):167–172.
   PubMed Web of Science ®Google Scholar
• Obonyo O, Fisher E, Edwards M, Douroumis D. 2010. Quantum dots synthesis and biological applications as imaging and drug delivery systems. Crit Rev Biotechnol 30:283–301.
   PubMed Web of Science ®Google Scholar
• Park EJ, Yoon J, Choi K, Yi J, Park K. 2009. Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation. Toxicology 260:37–46.
   PubMed Web of Science ®Google Scholar
• Pejnovic N, Tomic O, Vojvodic D, Djordjevic N, Jovicic Z, Kukic Z, 1994. IL-1, TNF and IL-6 production by alveolar mononuclear cells in patients with sarcoidosis. Srp Arh Celok Lek 122(Suppl 1):96–97.
   PubMedGoogle Scholar
• Qi L, Gao X2008. Emerging application of quantum dots for drug delivery and therapy. Expert Opin Drug Deliv 5:263–267.
   PubMed Web of Science ®Google Scholar
• Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. 2006. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 91:159–165.
   PubMed Web of Science ®Google Scholar
• Schuyler M, Gott K, Cherne A. 2000. Mediators of hypersensitivity pneumonitis. J Lab Clin Med 136:29–38.
   PubMed Web of Science ®Google Scholar
• Veronese FM, Pasut G. 2005. PEGylation, successful approach to drug delivery. Drug Discov Today 10:1451–1458.
   PubMed Web of Science ®Google Scholar
• Xing Y, Smith AM, Agrawal A, Ruan G, Nie S. 2006. Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots. Int J Nanomedicine 1:473–481.
   Web of Science ®Google Scholar
• Zhang H, Yee D, Wang C. 2008. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine (Lond) 3:83–91.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu J, Tang Y, Chen X, Yang Y. 2009. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery. Drug Dev Ind Pharm 35:1059–1065.
   PubMed Web of Science ®Google Scholar